You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • AB0565 Discontinuance of methotrexate and prednisolone in treatment with tocilizumab but not with infliximab or etanercept in rheumatoid arthritis patients with high disease activity. (Monotherapy by tocilizumab)

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Abstracts accepted for publication
Rheumatoid arthritis – other biologic treatment
AB0565 Discontinuance of methotrexate and prednisolone in treatment with tocilizumab but not with infliximab or etanercept in rheumatoid arthritis patients with high disease activity. (Monotherapy by tocilizumab)

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014700
Mar 20141501
Apr 2014700
May 2014100
Jun 2014300
Jul 2014200
Aug 2014600
Sep 20141000
Oct 2014400
Nov 2014400
Dec 2014301
Jan 2015200
Feb 2015501
Mar 2015400
Apr 2015700
May 2015601
Jul 2015300
Aug 20152108
Sep 2015700
Oct 2015400
Nov 2015602
Dec 2015100
Jan 2016100
Feb 2016300
Mar 2016300
Apr 2016700
May 2016300
Jun 2016600
Jul 2016400
Aug 2016200
Sep 2016400
Oct 2016700
Nov 2016200
Dec 2016300
Jan 2017200
Feb 2017100
Mar 2017400
Apr 20171002
May 20171100
Jun 2017700
Jul 2017600
Aug 2017800
Sep 20171000
Oct 2017800
Nov 2017600
Dec 2017600
Jan 2018600
Feb 2018200
Mar 2018400
Apr 20181000
May 20181601
Jun 20183800
Jul 20181601
Aug 2018400
Sep 2018200
Oct 2018200
Nov 2018200
Feb 2019800
Apr 2019200
Jul 2019400
Sep 2019200
Oct 2019200
Apr 2020200
Jun 2020400
Jul 2020800
Aug 2020100
Sep 2020800
Nov 2020200
Dec 2020600
Jan 2021200
Feb 2021100
Mar 2021200
Apr 2021600
Jul 2021001
Aug 2021100
Oct 2021400
Nov 20211401
Dec 20211000
Jan 2022400
Feb 2022601
Mar 2022600
Apr 2022300
May 2022600
Jun 2022200
Jul 20222600
Aug 20221000
Sep 2022600
Oct 2022600
Nov 2022600
Dec 2022600
Jan 2023200
Feb 2023600
Mar 2023200
May 2023400
Jun 2023200
Jul 2023600
Aug 2023200
Sep 2023600
Oct 2023200
Dec 2023600
Jan 2024200
Feb 2024200
Mar 2024200
Total574021